Paul Alloway
Concord, Massachusetts, United States
2K followers
500+ connections
2K followers
500+ connections
Activity
-
Great to kick off JPM 2026 with two deal announcements! I am excited to share that Novartis has signed: • A worldwide licensing agreement with…
Great to kick off JPM 2026 with two deal announcements! I am excited to share that Novartis has signed: • A worldwide licensing agreement with…
Liked by Paul Alloway
-
Very excited to finally unveil Aurora Therapeutics! We built Aurora with the vision of transforming personalized gene editing from heroic one-off…
Very excited to finally unveil Aurora Therapeutics! We built Aurora with the vision of transforming personalized gene editing from heroic one-off…
Liked by Paul Alloway
-
Nice start to 2026 for Lumira Ventures portfolio company Nocion Therapeutics, Inc. #ChronicCough
Nice start to 2026 for Lumira Ventures portfolio company Nocion Therapeutics, Inc. #ChronicCough
Liked by Paul Alloway
Experience
-
Self-employed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
More activity by Paul
-
Today marks a professional milestone. I got to argue in the Court of Appeals for the Federal Circuit. I don’t know if I won or lost but I walked…
Today marks a professional milestone. I got to argue in the Court of Appeals for the Federal Circuit. I don’t know if I won or lost but I walked…
Liked by Paul Alloway
-
No better way to start the year than with a paper out Jan 1st in Science Magazine! Congratulations to Siddhant Jain and all our collaborators within…
No better way to start the year than with a paper out Jan 1st in Science Magazine! Congratulations to Siddhant Jain and all our collaborators within…
Liked by Paul Alloway
-
Thanks Nikhil Thatte and Lumira Ventures for the shoutout to Specific Biologics in the #LeadingBeyondTheLab Podcast! We echo that Dualase® genome…
Thanks Nikhil Thatte and Lumira Ventures for the shoutout to Specific Biologics in the #LeadingBeyondTheLab Podcast! We echo that Dualase® genome…
Liked by Paul Alloway
-
Great kickoff for 2026. Congratulations to both teams on this accomplishment!
Great kickoff for 2026. Congratulations to both teams on this accomplishment!
Liked by Paul Alloway
-
I’m happy to share that I’m starting a new position as Chief Executive Officer of the Genetic Medicines Division at Alloy Therapeutics, Inc.! I'm…
I’m happy to share that I’m starting a new position as Chief Executive Officer of the Genetic Medicines Division at Alloy Therapeutics, Inc.! I'm…
Liked by Paul Alloway
-
We loved getting together earlier this week for our Prime Medicine holiday party—an evening full of laughter, connection, and a little friendly…
We loved getting together earlier this week for our Prime Medicine holiday party—an evening full of laughter, connection, and a little friendly…
Liked by Paul Alloway
-
Today, we announced the FDA acceptance and Priority Review of the Biologics License Application (BLA) for veligrotug for the treatment of thyroid eye…
Today, we announced the FDA acceptance and Priority Review of the Biologics License Application (BLA) for veligrotug for the treatment of thyroid eye…
Liked by Paul Alloway
-
This week CAMP4 announced two major strategic moves. First, we announced a new multi-target discovery stage collaboration with GSK. We are…
This week CAMP4 announced two major strategic moves. First, we announced a new multi-target discovery stage collaboration with GSK. We are…
Liked by Paul Alloway
-
This morning Philips announced it is acquiring Lumira Ventures' portfolio company SpectraWAVE, Inc., a little over a year after we partnered with the…
This morning Philips announced it is acquiring Lumira Ventures' portfolio company SpectraWAVE, Inc., a little over a year after we partnered with the…
Liked by Paul Alloway
Other similar profiles
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content